Tracer-determined glucose fluxes in health and type 2 diabetes: basal conditions (Q35214630)

7 August 2017

title

Tracer-determined glucose fluxes in health and type 2 diabetes: basal conditions (English)

1 reference

7 August 2017

1 reference

Jerry Radziuk

1

1 reference

7 August 2017

Susan Pye

series ordinal

2

1 reference

7 August 2017

publication date

1 September 2003

1 reference

Best Practice and Research: Clinical Endocrinology and Metabolism

7 August 2017

published in

1 reference

7 August 2017

volume

17

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

323-342

1 reference

Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty acids, and amino acids

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Insulin sensitivity and its measurement: structural commonalities among the methods

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Insulin resistance, but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Measurement of post-absorptive glucose kinetics in non-insulin-dependent diabetic patients: methodological aspects

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Effect of time on measurement of hepatic glucose production

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Complications: neuropathy, pathogenetic considerations

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Polyols and myo-inositol in diabetic neuropathy--of mice and men

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Glucose toxicity in the vascular complications of diabetes: the cellular perspective

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

1 reference

7 January 2021

Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Perspective: Hexosamines and nutrient sensing

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Initial splanchnic extraction of ingested glucose in normal man.

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Tracer methods and the metabolic disposal of a carbohydrate load in man

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Production and metabolic clearance of glucose under basal conditions in Type II (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Influences of glucose loading and of injected insulin on hepatic glucose output

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Quantitation of basal endogenous glucose production in Type II diabetes: importance of the volume of distribution

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Glucose-2-t as a Tracer for Glucose Metabolism*

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Gluconeogenesis and related aspects of glycolysis

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Measuring glucose and fructose-6-phosphate cycling in liver in vivo

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Assessment of insulin action in insulin-dependent diabetes mellitus using [6(14)C]glucose, [3(3)H]glucose, and [2(3)H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man.

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Estimation of Glucose Turnover and the Cori Cycle Using Glucose-6-t-14C*

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Determination of pathways of glycogen synthesis and the dilution of the three-carbon pool with [U-13C]glucose

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Carbohydrate metabolism in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

The disposal of an oral glucose load in patients with non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

A suprachiasmatic nucleus generated rhythm in basal glucose concentrations

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Glucose turnover and disposal in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Role of liver in pathophysiology of NIDDM

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin.

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

Metformin and its liver targets in the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S1521-690X(03)50038-1

7 January 2021

10.1016/S1521-690X(03)00038-1

Identifiers

DOI

1 reference

7 August 2017

1 reference